Élan controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2010
Fine concerning epilepsy-drug marketing
In July 2010, Élan was fined $203 million in connection with its marketing of epilepsy drugs.
2002
Accounting scandal and market collapse
Élan experienced an accounting scandal in 2002. Investor reaction, combined with a global market slump, produced a collapse in confidence and a share-price decline of more than 90 percent.